Wall Street Journal (12.20.02) - Friday, December 20, 2002
Michael M. Phillips

In just four months, and at a cost of only $29,000, the US government-financed feature film "Awakening" has reached an audience estimated to number in the tens of millions, through theaters, national television broadcasts and black-market videos. "Awakening 2" is now in production. And the plot of "Awakening 3" is incubating at 2 Effects Empire, the Kano production company of 29-year-old Yakubu Mohammed and his 29- year-old partner Sani Musa Danja. Family Health International, a private aid group, manages the project for the US Agency for International Development.

In "Awakening," Danja plays Babangida, the promiscuous young man who evidently contracts HIV from Mariya, the poor vendor, who reluctantly sleeps with rich men to eke out a living. Babangida regrets his libertine ways when he meets the virginal Jamila. The first film ends in suspense as Babangida awaits his HIV test results. The movie never mentions condoms, and a local cleric cleared its message of faithfulness and premarital abstinence.

The filmmakers are now stuck on the cliffhanger: Should rakish Babangida, who has HIV, marry the love of his life, Jamila, who doesn't? Or should he leave her at the altar and marry Mariya, the beautiful, HIV-positive street vendor? "If we really want to stop the spread of AIDS, we have to take our religion into account," said Mohammed. So Babangida should pick Mariya, he argued, because Islamic teaching requires the sick to isolate themselves from the healthy - even though Western AIDS activists frown on anything that smacks of stigma.

While the Nigerian Health Ministry estimates that nearly 6 percent of adults ages 15 to 49 nationwide are HIV-infected, a recent Central Intelligence Agency study predicts that as many as 26 percent of adult Nigerians will carry the virus by the year 2010 unless drastic steps are taken.
021220
AD022469

Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.